PT2039356E - Composição sialagoga à base de um agonista muscarínico m3 e de um antagonista adrenérgico alfa-2 - Google Patents

Composição sialagoga à base de um agonista muscarínico m3 e de um antagonista adrenérgico alfa-2

Info

Publication number
PT2039356E
PT2039356E PT83680173T PT08368017T PT2039356E PT 2039356 E PT2039356 E PT 2039356E PT 83680173 T PT83680173 T PT 83680173T PT 08368017 T PT08368017 T PT 08368017T PT 2039356 E PT2039356 E PT 2039356E
Authority
PT
Portugal
Prior art keywords
sialagogue
alpha
composition
adrenergic antagonist
muscarinic agonist
Prior art date
Application number
PT83680173T
Other languages
English (en)
Inventor
Isabelle Madinier
Original Assignee
Univ Nice Sophia Antipolis
Ct Hospitalier Universitaire Nice
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nice Sophia Antipolis, Ct Hospitalier Universitaire Nice filed Critical Univ Nice Sophia Antipolis
Publication of PT2039356E publication Critical patent/PT2039356E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT83680173T 2007-09-20 2008-09-12 Composição sialagoga à base de um agonista muscarínico m3 e de um antagonista adrenérgico alfa-2 PT2039356E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0706596A FR2921268B1 (fr) 2007-09-20 2007-09-20 Composition sialagogue

Publications (1)

Publication Number Publication Date
PT2039356E true PT2039356E (pt) 2013-10-23

Family

ID=39190370

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83680173T PT2039356E (pt) 2007-09-20 2008-09-12 Composição sialagoga à base de um agonista muscarínico m3 e de um antagonista adrenérgico alfa-2

Country Status (6)

Country Link
EP (1) EP2039356B1 (pt)
DK (1) DK2039356T3 (pt)
ES (1) ES2430599T3 (pt)
FR (1) FR2921268B1 (pt)
PL (1) PL2039356T3 (pt)
PT (1) PT2039356E (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX338801B (es) * 2011-05-16 2016-05-02 Colgate Palmolive Co Composiciones de cuidado oral.
RU2496469C2 (ru) * 2012-01-11 2013-10-27 Владимир Николаевич Иванов Безабразивная зубная паста, содержащая фермент папаин, экстракт сфагнума, натрий-кальциевую соль сополимера полиметилвинилового спирта и малеиновой кислоты, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид
RU2487698C1 (ru) * 2012-01-11 2013-07-20 Сергей Борисович Улитовский Безабразивная зубная паста, содержащая фермент папаин, экстракт гарпагофитума, d,l-пирролидонкарбоксилат n-кокоил этиларгината и натрия фторид

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1965787B1 (en) * 2005-11-30 2013-04-10 Endo Pharmaceuticals Inc. Treatment of xerostomia with a sulfur-containing antioxidant

Also Published As

Publication number Publication date
FR2921268A1 (fr) 2009-03-27
EP2039356B1 (fr) 2013-07-10
PL2039356T3 (pl) 2014-03-31
EP2039356A1 (fr) 2009-03-25
ES2430599T3 (es) 2013-11-21
FR2921268B1 (fr) 2010-02-26
DK2039356T3 (da) 2013-10-14

Similar Documents

Publication Publication Date Title
JO2797B1 (en) Selective opioid receptor antagonist kappa
LUC00077I2 (en) Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
MX2012004134A (es) Terapia de combinacion usando un agonista del receptor adrenergico beta 3 y un agente antimuscarinico.
WO2009051824A3 (en) Combination analgesic employing opioid and neutral antagonist
MX2010000724A (es) Metodo para reducir presion intracraneal.
SG155880A1 (en) Multiparticulates of preferably an opioid, and method of manufacturing using extrusion
NZ600125A (en) Methods of treating or preventing acute erythema
HK1097197A1 (en) Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
EP1971355A4 (en) METHOD AND COMPOSITIONS FOR THE DISPOSAL OF ACTIVE SUBSTANCES WITH IMPROVED PHARMACOLOGICAL PROPERTIES
MX2009005724A (es) Comprimidos bicapa de estrogenos/serm y estrogenos/progestina.
PT1986642E (pt) Combinação de agonista do receptor alfa-2 (clonidina) e um agente antimuscarínico (oxibutinina) para o tratamento de sialorreia
MX353105B (es) Combinaciones de agonistas del receptor beta-3-adrenergico y antagonistas del receptor muscarinico para tratar vejiga hiperactiva.
EP2360173A4 (en) CYTOTOXIC LYMPHOCYTE T EPITOPE PEPTIDE FOR SARS CORONAVIRUS, AND USE THEREOF
PL2240018T3 (pl) Kompozycja zawierająca środek przeciwbólowy i przeciwhistaminowy
GEP20146078B (en) Processes for pharmaceutically active agent manufacture
CL2011000044A1 (es) Uso de una composicion farmaceutica oral que comprende al menos un antagonista opioide seleccionado de naloxona, naltrexona, nalbufino o sus sales, adicionalmente puede comprender al menos un agonista opioide, tal como oxicodona, morfina u otros, para el tratamiento de la retencion urinaria.
PT2039356E (pt) Composição sialagoga à base de um agonista muscarínico m3 e de um antagonista adrenérgico alfa-2
HK1155943A1 (en) Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical composition containing same and use thereof in the treatment of cognitive disorders
TWI368152B (en) Dynamic redundancy checker against fault injection
MX2009008191A (es) Medicamento para el tratamiento de endometriosis.
WO2007026219A3 (en) Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
WO2008078729A1 (ja) 溶出性改善方法
GEP20135792B (en) Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and use of the same
WO2005089441A3 (en) Methods for increasing neurotransmitter levels using hydroxycitric acid
WO2010033862A3 (en) Methods for treating cancer using npar agonists